Have a personal or library account? Click to login
Platelet indices in Philadelphia-negative chronic myeloproliferative neoplasms / Indicii plachetari de volum în neoplasmele mieloproliferative cronice Philadelphia-negative Cover

Platelet indices in Philadelphia-negative chronic myeloproliferative neoplasms / Indicii plachetari de volum în neoplasmele mieloproliferative cronice Philadelphia-negative

Revista Romana de Medicina de Laborator
Volume 23 (2015): Issue 2 (June 2015)
By: Ariela-Ligia Olteanu,  Romeo-Gabriel Mihaila,  Alina-Camelia Catana,  Ofelia Flucus,  Cristina Bus and  Manuela Mihalache  
Open Access
|Jun 2015

References

  1. 1. Vardiman JW, Brunning RD, Arber DA, Lebean MM, Porurt A, Telferi A, et al. Introduction and Overview of the Classification of the Myeloid Neoplasms. In: Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, et al. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. 4th edition. IARC, Lyon. 2008;18-49.
    Search in Google Scholar
  2. 2. Campbell PJ, Green AR. The myeloproliferative disorders. N Engl J Med. 2006 Dec;355(23):2452-66. DOI: 10.1056/NEJMra06372810.1056/NEJMra06372817151367
    Search in Google Scholar
  3. 3. Falanga A, Marchetti M. Thrombotic disease in the myeloproliferative neoplasms. Hematology Am Soc HematolEduc Program. 2012 Dec;2012(1):571-81.10.1182/asheducation.V2012.1.571.3798557
    Search in Google Scholar
  4. 4. Barbui T, Finazzi G, Falanga A. Myeloproliferative neoplasms and thrombosis.Blood. 2013 Mar;122(13):2176-84. DOI: 10.1182/blood-2013-03-46015410.1182/blood-2013-03-46015423823316
    Search in Google Scholar
  5. 5. Landolfi R, Di Gennaro I, Falanga A. Thrombosis in myeloproliferative disorders: pathogenic facts and speculation. Leukemia. 2008 Nov;22(11):2020-8. DOI: 10.1038/leu.2008.25310.1038/leu.2008.25318800144
    Search in Google Scholar
  6. 6. Arellano-Rodrigo E, Alvarez-Larran A, Reverter JC, Villamor N, Colomer D, Cervantes F. Increased platelet and leukocyte activation as contributing mechanisms for thrombosis in essential thrombocythemia and correlation with JAK2 mutation status. Haematologica. 2006 Feb;91(2):169-75.
    Search in Google Scholar
  7. 7. Panova-Noeva M, Marchetti M, Russo L, Tartari CJ, Leuzzi A, Finazzi G, et al. ADP-induced platelet aggregation and thrombin generation are increased in Essential Thrombocythemia and Polycythemia Vera. Thromb Res. 2013 Jul;132(1):88-93. DOI: 10.1016/j. thromres.2013.05.003
    Search in Google Scholar
  8. 8. Machin SJ, Briggs C. Mean platelet volume: a quick, easy determinant of thrombotic risk? J Thromb Haemost. 2010 Jan;8(1);146-7. DOI: 10.1111/j.1538-7836.2009.03673.x10.1111/j.1538-7836.2009.03673.x19874471
    Search in Google Scholar
  9. 9. Demirin H, Ozhan H, Ucgun T, Celer A, Bulur S, Cil H, et al. Normal range of mean platelet volume in healthy subjects: Insight from a large epidemiologic study. Thromb Res. 2011 Oct;128(4):358-60. DOI: 10.1016/j. thromres.2011.05.007
    Search in Google Scholar
  10. 10. Riedl J, Pabinger I, Ay C. Platelets in cancer and thrombosis. Hämostaseologie. 2014 Feb;34(1):54-62. DOI: 10.5482/HAMO-13-10-005410.5482/HAMO-13-10-005424305775
    Search in Google Scholar
  11. 11. Leader A, Pereg D, Lishner M. Are platelet indices of clinical use? A multidisciplinary review. Ann Med. 2012 Dec;44(8):805-16. DOI: 10.3109/07853890.2011.65339110.3109/07853890.2011.65339122413913
    Search in Google Scholar
  12. 12. Chu SG, Becker RC, Berger PB, Bhatt DL, Eikelboom JW, Konkle B, et al. Mean platelet volume as a predictor of cardiovascular risk: a systematic review and meta- analysis. J Thromb Haemost. 2010 Jan;8(1):148-56. DOI: 10.1111/j.1538-7836.2009.03584.x10.1111/j.1538-7836.2009.03584.x375549619691485
    Search in Google Scholar
  13. 13. Klovaite J, Benn M, Yazdanyar S, Nordestgaard BG. High platelet volume and increased risk of myocardial infarction: 39,531 participants from the general population. J Thromb Haemost. 2011 Jan;9(1):49-56. DOI: 10.1111/j.1538-7836.2010.04110.x10.1111/j.1538-7836.2010.04110.x20942852
    Search in Google Scholar
  14. 14. Muscari A, Puddu GM, Cenni A, Silvestri MG, Giuzio R, Rosati M, et al. Mean platelet volume (MPV) increase during acute non-lacunar ischemic strokes. Thromb Res. 2009 Feb; 123(4):587-91. DOI: 10.1016/j. thromres.2008.03.025
    Search in Google Scholar
  15. 15. Brækkan SK, Mathiesen EB, Njølstad I, Wilsgaard T, Størmer J, Hansen JB. Mean platelet volume is a risk factor for venous thromboembolism: the Tromsø study. J Thromb Haemost. 2010 Jan;8(1):157-62. DOI: 10.1111/j.1538-7836.2009.03498.x10.1111/j.1538-7836.2009.03498.x19496920
    Search in Google Scholar
  16. 16. Gohda F, Uchiumi H, Handa H, Matsushima T, Tsukamoto N, Morita K, et al. Identification of inherited macrothrombocytopenias based on mean platelet volume among patients diagnosed with idiopathic thrombocytopenia. Thromb Res. 2007;119(6):741-6. DOI: 10.1016/j.thromres.2006.06.01110.1016/j.thromres.2006.06.01116916536
    Search in Google Scholar
  17. 17. Thiele J, Imbert M, Pierre R, Vardiman JW, Brunning RD, Flandrin G. Chronic idiopathic myelofibrosis. In: Jaffe ES, Harris NL, Stein H, Vardiman JW, eds.WHO Classification of Tumours: Tumours of Haematopoietic and Lymphoid Tissues. Lyon, France: IARC Press; 2001:35-38.
    Search in Google Scholar
  18. 18. Jones AV, Kreil S, Zoi K, Waghorn K, Curtis C, Zhang L, et al. Widespread occurrence of the JAK2 V617F mutation in chronic myeloproliferative disorders. Blood, 2005 Sep;106 (6):2162-68. DOI: 10.1182/ blood-2005-03-132010.1182/blood-2005-03-132015920007
    Search in Google Scholar
  19. 19. Lippi G, Meschi T, Borghi L. Mean platelet volume increases with aging in a large population study. Thromb Res. 2012 Apr;129(4):e159-60. DOI: 10.1016/j.thromres. 2011.12.031
    Search in Google Scholar
  20. 20. Zhang J, Huang W. Reference range of mean platelet volume in Chinese individuals. Thromb Res. 2014 Mar;133(3):517-8. DOI: 10.1016/j.thromres. 2013.12.011
    Search in Google Scholar
  21. 21. Cho SY, Lee HJ, Lee WI, Suh JT, Park TS. Large population study for the reference range of mean platelet volume in Korean individuals. Thromb Res. 2012 Sep;130(3):557-8. DOI: 10.1016/j.thromres. 2012.05.009
    Search in Google Scholar
  22. 22. Meisinger C, Prokisch H, Gieger C, Soranzo N, Mehta D, Rosskopf D, et al. A genome-wide association study indentifies three loci associated with mean platelet volume. Am J Hum Genet. 2009 Jan;84(1);66-71. DOI: 10.1016/j.ajhg.2008.11.01510.1016/j.ajhg.2008.11.015266803619110211
    Search in Google Scholar
  23. 23. Lancé MD, van Oerle R, Henskens YM, Marcus MA. Do we need time adjusted mean platelet volume measurements? Lab Hematol. 2010 Sep;16(3):28-31. DOI: 10.1532/LH96.1001110.1532/LH96.1001120858586
    Search in Google Scholar
  24. 24. Vinholt JP, Hvas AM, Nybo M. An overview of platelet indices and methods for evaluation platelet function in thrombocytopenic patients. Eur J Haematol. 2014 Jun;92(5):367-76. DOI: 10.1111/ejh.1226210.1111/ejh.1226224400878
    Search in Google Scholar
  25. 25. Arellano-Rodrigo E, Alvarez-Larran A, Reverter JC, Villamor N, Jou JM, Cervantes F. Automated assessment of the neutrophil and platelet activation status in patients with essential thrombocythemia. Platelets. 2012 Aug;23(5):336-43. DOI: 10.3109/09537104.2011.63011210.3109/09537104.2011.63011222059534
    Search in Google Scholar
  26. 26. Riedl J, Kaider A, Reitter EM, Marosi C, Jäger U, Schwarzinger I, et al. Association of mean platelet volume with risk of venous thromboembolism and mortality in patients with cancer. Thromb Haemost. 2014 Apr;111(4):670-8. DOI: 10.1160/TH13-07-060310.1160/TH13-07-060324306221
    Search in Google Scholar
  27. 27. Latger-Cannard V, Hoarau M, Salignac S, Baumgart P, Lecompte T, Nurden P. Mean platelet volume: comparison of three analysers towards standardization of platelet morphological phenotype. Int Jnl Lab Hem. 2012 Jun;34(3):300-10. DOI: 10.1111/j.1751-553X.2011.01396.x10.1111/j.1751-553X.2011.01396.x22225539
    Search in Google Scholar
  28. 28. Colita A, Butoianu E, Nicoara S. Boli clonale ale celulelor stem hematopoietice. In: Paun R. Tratat de Me dicina Interna, Hematologie, partea aIIa,Editura Medicala, Bucuresti. 1999;164-84.
    Search in Google Scholar
  29. 29. Bain BJ, Disorders of red cells and platelets. In: Blood cells: A Practical Guide. 4th edition. Blackwell Publishing, Carlton, Victoria. 2006;283-97. DOI: 10.1002/9780470987551. ch8 DOI: 10.1002/9780470987551 DOI: 10.1002/9780470987551.ch910.1002/9780470987551
    Search in Google Scholar
  30. 30. Shah B, Valdes V, Nardi MA, Hu L, Schrem E, Berger IS. Mean platelet volume reproductibility and association with platelet activity and anti-platelet therapy. Platelets. 2014;25(3):188-92. DOI: 10.3109/09537104.2013.79379410.3109/09537104.2013.793794380902123786366
    Search in Google Scholar
  31. 31. Panova-Noeva M, Marcetti M, Buoro S, Russo L, Leuzzi A, Finazzi G, et al.Jak2V617F mutation and hydroxyurea treatment as determinants of immature platelet parameters in essential thrombocythemia and polycythemia vera patients. Blood. 2011 Sep;118(9):2599-601. DOI: 10.1182/blood-2011-02-33965510.1182/blood-2011-02-33965521750318
    Search in Google Scholar
  32. 32. Bellucci S, Legrand C, Boval B, Drouet L, Caen J. Studies of platelet volume, chemistry and function in patients with essential thrombocythaemia treated with Anagrelide. Brit J Haematol 1999;104:886-892. DOI: 10.1046/j.1365-2141.1999.01234.x10.1046/j.1365-2141.1999.01234.x10192455
    Search in Google Scholar
  33. 33. Coban E, Afacan B. The effect of rosuvastatin treatment on the mean platelet volume in patients with uncontrolled primary dyslipidemia with hipolipidemic diet treatment. Platelets. 2008 Mar;19(2):111-4. DOI: 10.1080/0953710070123044410.1080/0953710070123044417852772
    Search in Google Scholar
  34. 34. Carobbio A, Finazzi G, Anatonioli E, Guglielmelli P, Vannucchi AM, Dellacasa CM, et al. JAK2V617F allele burden and thrombosis: a direct comparison in essential thrombocythemia and polycythemia vera. Exp Hematol. 2009 Sep;37(9):1016-21. DOI: 10.1016/j. exphem.2009.06.006
    Search in Google Scholar
  35. 35. Falanga A, Marchetti M, Vignoli A, Balducci D, Russo L, Guerini V, et al. V617F JAK-2 mutation in patients with essential thrombocythemia: relation to platelet, granulocyte, and plasma hemostatic and inflammatory molecules. Exp Hematol. 2007 May;35(5):702-11. DOI: 10.1016/j.exphem.2007.01.053 10.1016/j.exphem.2007.01.05317577920
    Search in Google Scholar
DOI: https://doi.org/10.1515/rrlm-2015-0012 | Journal eISSN: 2284-5623 | Journal ISSN: 1841-6624
Journal RSS Feed
Language: English
Page range: 169 - 177
Submitted on: Jan 8, 2015
|
Accepted on: May 29, 2015
|
Published on: Jun 23, 2015
Published by: Romanian Association of Laboratory Medicine
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Keywords:
chronic myeloproliferative neoplasms,
platelet activation,
platelet volume indices
Related subjects:
Life sciences,
Molecular biology,
Biochemistry,
Human biology,
Microbiology and virology

© 2015 Ariela-Ligia Olteanu, Romeo-Gabriel Mihaila, Alina-Camelia Catana, Ofelia Flucus, Cristina Bus, Manuela Mihalache, published by Romanian Association of Laboratory Medicine
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.

Previous articleVolume 23 (2015): Issue 2 (June 2015)Next article